Spironolactone Tablet, Film Coated
Product Images NDC 0378-0243

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 0378-0243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Tablets, Usp 50 mg Bottle Label (Image 01)

Chemical structure diagram of spironolactone, the active ingredient in Spironolactone tablets by Mylan Pharmaceuticals Inc. The structure includes characteristic rings and functional groups typical of this molecule.*

FDA Label Image

Image 02

A line graph showing the probability over time in months for two groups: spironolactone (n=822) and placebo (n=841). The y-axis represents probability from 0.0 to 1.0, and the x-axis represents time in months from 0 to 48. The spironolactone group shows a higher probability over time compared to placebo, with a log-rank p-value less than 0.001, suggesting statistical significance.*

FDA Label Image

Image 03

Forest plot chart depicting hazard ratios (HR) and 95% confidence intervals (CI) across various patient subgroups for spironolactone versus placebo effectiveness. Subgroups are categorized by age, sex, race, LVEF %, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and concurrent medication use including digoxin, ACE inhibitors, and beta blockers.*

FDA Label Image

Image 04

Label for Spironolactone 25 mg film-coated tablets by Mylan Pharmaceuticals Inc. The label indicates an oral dosage form, with a package containing 100 tablets. It displays the NDC number 0378-2146-01, dosage strength, and storage instructions, including keeping the container tightly closed and protected from light at controlled room temperature.*

FDA Label Image

Image 05

Packaging label for Spironolactone 50 mg film-coated tablets, USP, by Mylan Pharmaceuticals Inc. The label shows the NDC 0378-0243-01, indicating a package of 100 tablets. The label includes storage instructions, dosage form, route (oral), and safety warnings about keeping medication out of children’s reach.*

FDA Label Image

Image 06

Label for Spironolactone 100 mg film-coated tablets, USP, by Mylan Pharmaceuticals Inc. The label shows the NDC 0378-0437-01, includes dosage strength (100 mg), tablet count (100 tablets), and the Mylan logo. It provides storage instructions and safety warnings about dispensing, child-resistant closure, and keeping out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.